| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |